Kyverna Therapeutics, Inc. Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Kyverna Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2023 to Q3 2024.
  • Kyverna Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending September 30, 2024 was -$226M.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 -$226M Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$192M Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$163M Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$136M Dec 31, 2023 10-Q 2024-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.